Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

818 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cutaneous manifestations induced by check point inhibitors in 120 melanoma patients-The European MelSkinTox study.
L'Orphelin JM, Cassecuel J, Kandolf L, Harwood CA, Tookey P, Junejo MH, Hogan S, Lebbé C, Appalla Z, Kränke TM, Pellacani G, Cerasuolo D, Dujovic B, Del Marmol V, Forschner A, Garbe C, Bataille V, Ressler JM, Sollena P, Dompmartin A, Peris K, Dreno B; And European Association of Dermato-Oncology. L'Orphelin JM, et al. Among authors: dreno b. J Eur Acad Dermatol Venereol. 2023 Apr 12. doi: 10.1111/jdv.19112. Online ahead of print. J Eur Acad Dermatol Venereol. 2023. PMID: 37042810
Melanoma-associated retinopathy treated with ipilimumab therapy.
Audemard A, de Raucourt S, Miocque S, Comoz F, Giraud JM, Dreno B, Bienvenu B, Rogerie MJ, Dompmartin A. Audemard A, et al. Among authors: dreno b. Dermatology. 2013;227(2):146-9. doi: 10.1159/000353408. Epub 2013 Sep 14. Dermatology. 2013. PMID: 24051549
Cutaneous melanoma in patients treated with tumour necrosis factor inhibitors: a retrospective series of 15 patients.
Chabbert C, Adamski H, Guillet G, Sassolas B, Misery L, Perrinaud A, Machet L, Quereux G, Esteve E, Solau-Gervais E, Saraux A, Polard E, Lesimple T, Le Gall F, Dreno B, Dupuy A. Chabbert C, et al. Among authors: dreno b. J Eur Acad Dermatol Venereol. 2014 Nov;28(11):1540-4. doi: 10.1111/jdv.12347. Epub 2013 Dec 13. J Eur Acad Dermatol Venereol. 2014. PMID: 24329560
Profile of vemurafenib-induced severe skin toxicities.
Peuvrel L, Quéreux G, Saint-Jean M, Brocard A, Nguyen JM, Khammari A, Knol AC, Varey E, Dréno B. Peuvrel L, et al. Among authors: dreno b. J Eur Acad Dermatol Venereol. 2016 Feb;30(2):250-7. doi: 10.1111/jdv.13443. Epub 2015 Nov 2. J Eur Acad Dermatol Venereol. 2016. PMID: 26524690
Histopathological aspects of cutaneous erythematous-papular eruptions induced by immune checkpoint inhibitors for the treatment of metastatic melanoma.
Perret RE, Josselin N, Knol AC, Khammari A, Cassecuel J, Peuvrel L, Dreno B; Supported by GESTIM Nantes group of cutaneous adverse events induced by anticancer drugs. Perret RE, et al. Among authors: dreno b. Int J Dermatol. 2017 May;56(5):527-533. doi: 10.1111/ijd.13540. Epub 2017 Feb 10. Int J Dermatol. 2017. PMID: 28188628
Defining the actinic keratosis field: a literature review and discussion.
Figueras Nart I, Cerio R, Dirschka T, Dréno B, Lear JT, Pellacani G, Peris K, Ruiz de Casas A; Progressing Evidence in AK (PEAK) Working Group. Figueras Nart I, et al. Among authors: dreno b. J Eur Acad Dermatol Venereol. 2018 Apr;32(4):544-563. doi: 10.1111/jdv.14652. Epub 2017 Nov 24. J Eur Acad Dermatol Venereol. 2018. PMID: 29055153 Free article. Review.
Safety and immunogenicity of MAGE-A3 cancer immunotherapeutic with dacarbazine in patients with MAGE-A3-positive metastatic cutaneous melanoma: an open phase I/II study with a first assessment of a predictive gene signature.
Grob JJ, Mortier L, D'Hondt L, Grange F, Baurain JF, Dréno B, Lebbe C, Robert C, Dompmartin A, Neyns B, Gillet M, Louahed J, Jarnjak S, Lehmann FF. Grob JJ, et al. Among authors: dreno b. ESMO Open. 2017 Nov 14;2(5):e000203. doi: 10.1136/esmoopen-2017-000203. eCollection 2017. ESMO Open. 2017. PMID: 29177094 Free PMC article.
TOXICAN: a guide for grading dermatological adverse events of cancer treatments.
Peuvrel L, Cassecuel J, Bernier C, Quéreux G, Saint-Jean M, Le Moigne M, Frénard C, Khammari A, Dréno B; Supported by GESTIM Nantes group of cutaneous adverse events induced by cancer treatments. Peuvrel L, et al. Among authors: dreno b. Support Care Cancer. 2018 Aug;26(8):2871-2877. doi: 10.1007/s00520-018-4153-x. Epub 2018 Mar 12. Support Care Cancer. 2018. PMID: 29532244
818 results